Dry-powder inhalation capsules provide a maior drug development opportunity for pulmonary treatments and systemic applications.
Lonza's Capsugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio offers the most complete portfolio of DPl capsules with targeted emitted dose that are tailored toward formulation properties and inhalation device. The high-quality customizable capsule solutions based on different polymers and compositions are supported by a wide range of services within Lonza.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.
If you have any questions, our experts are here to help.
Access all of the latest news, white papers, webinars and knowledge center resources.